FNQ.CX Quote, Financials, Valuation and Earnings

ThreeD Capital, Inc. has a net margin of -340.38% compared to Fineqia International, Inc.'s net margin of -632.46%. Fineqia International, Inc.'s return on equity of -- beat ThreeD Capital, Inc.'s return on equity of -54.82%.

Fineqia International, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand ThreeD Capital, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fineqia International, Inc. has higher upside potential than ThreeD Capital, Inc., analysts believe Fineqia International, Inc. is more attractive than ThreeD Capital, Inc..

Fineqia International, Inc. has a beta of 1.809, which suggesting that the stock is 80.905% more volatile than S&P 500. In comparison ThreeD Capital, Inc. has a beta of 0.015, suggesting its less volatile than the S&P 500 by 98.466%.

Fineqia International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ThreeD Capital, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fineqia International, Inc. pays -- of its earnings as a dividend. ThreeD Capital, Inc. pays out -- of its earnings as a dividend.

Fineqia International, Inc. quarterly revenues are $148.1K, which are smaller than ThreeD Capital, Inc. quarterly revenues of $447K. Fineqia International, Inc.'s net income of -$504.1K is higher than ThreeD Capital, Inc.'s net income of -$2.8M. Notably, Fineqia International, Inc.'s price-to-earnings ratio is -- while ThreeD Capital, Inc.'s PE ratio is 3.44x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fineqia International, Inc. is 8.01x versus 1.44x for ThreeD Capital, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

MedBright AI Investments, Inc. has a net margin of -340.38% compared to Fineqia International, Inc.'s net margin of -179.59%. Fineqia International, Inc.'s return on equity of -- beat MedBright AI Investments, Inc.'s return on equity of 40.84%.

Fineqia International, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand MedBright AI Investments, Inc. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fineqia International, Inc. has higher upside potential than MedBright AI Investments, Inc., analysts believe Fineqia International, Inc. is more attractive than MedBright AI Investments, Inc..

Fineqia International, Inc. has a beta of 1.809, which suggesting that the stock is 80.905% more volatile than S&P 500. In comparison MedBright AI Investments, Inc. has a beta of 1.312, suggesting its more volatile than the S&P 500 by 31.221%.

Fineqia International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. MedBright AI Investments, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fineqia International, Inc. pays -- of its earnings as a dividend. MedBright AI Investments, Inc. pays out -- of its earnings as a dividend.

Fineqia International, Inc. quarterly revenues are $148.1K, which are larger than MedBright AI Investments, Inc. quarterly revenues of $114K. Fineqia International, Inc.'s net income of -$504.1K is lower than MedBright AI Investments, Inc.'s net income of $347.4K. Notably, Fineqia International, Inc.'s price-to-earnings ratio is -- while MedBright AI Investments, Inc.'s PE ratio is 8.10x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fineqia International, Inc. is 8.01x versus 6.15x for MedBright AI Investments, Inc.. Usually stocks with elevated PS ratios are considered overvalued.

Quinsam Capital Corp. has a net margin of -340.38% compared to Fineqia International, Inc.'s net margin of -3.32%. Fineqia International, Inc.'s return on equity of -- beat Quinsam Capital Corp.'s return on equity of -41.93%.

Fineqia International, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Quinsam Capital Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fineqia International, Inc. has higher upside potential than Quinsam Capital Corp., analysts believe Fineqia International, Inc. is more attractive than Quinsam Capital Corp..

Fineqia International, Inc. has a beta of 1.809, which suggesting that the stock is 80.905% more volatile than S&P 500. In comparison Quinsam Capital Corp. has a beta of 0.680, suggesting its less volatile than the S&P 500 by 32.05%.

Fineqia International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Quinsam Capital Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fineqia International, Inc. pays -- of its earnings as a dividend. Quinsam Capital Corp. pays out -- of its earnings as a dividend.

Fineqia International, Inc. quarterly revenues are $148.1K, which are larger than Quinsam Capital Corp. quarterly revenues of -$4M. Fineqia International, Inc.'s net income of -$504.1K is lower than Quinsam Capital Corp.'s net income of $132.1K. Notably, Fineqia International, Inc.'s price-to-earnings ratio is -- while Quinsam Capital Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fineqia International, Inc. is 8.01x versus -- for Quinsam Capital Corp.. Usually stocks with elevated PS ratios are considered overvalued.

Humanoid Global Holdings Corp. has a net margin of -340.38% compared to Fineqia International, Inc.'s net margin of -15445.34%. Fineqia International, Inc.'s return on equity of -- beat Humanoid Global Holdings Corp.'s return on equity of -548.95%.

Fineqia International, Inc. has a consensus price target of --, signalling downside risk potential of --. On the other hand Humanoid Global Holdings Corp. has an analysts' consensus of -- which suggests that it could fall by --. Given that Fineqia International, Inc. has higher upside potential than Humanoid Global Holdings Corp., analysts believe Fineqia International, Inc. is more attractive than Humanoid Global Holdings Corp..

Fineqia International, Inc. has a beta of 1.809, which suggesting that the stock is 80.905% more volatile than S&P 500. In comparison Humanoid Global Holdings Corp. has a beta of 4.043, suggesting its more volatile than the S&P 500 by 304.327%.

Fineqia International, Inc. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Humanoid Global Holdings Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Fineqia International, Inc. pays -- of its earnings as a dividend. Humanoid Global Holdings Corp. pays out -- of its earnings as a dividend.

Fineqia International, Inc. quarterly revenues are $148.1K, which are larger than Humanoid Global Holdings Corp. quarterly revenues of $16.1K. Fineqia International, Inc.'s net income of -$504.1K is higher than Humanoid Global Holdings Corp.'s net income of -$2.5M. Notably, Fineqia International, Inc.'s price-to-earnings ratio is -- while Humanoid Global Holdings Corp.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Fineqia International, Inc. is 8.01x versus 561.40x for Humanoid Global Holdings Corp.. Usually stocks with elevated PS ratios are considered overvalued.